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Short Communication
Crohn's disease (CD) together with the ulcerative colitis belongs to the inflammatory bowel 
diseases. CD is a chronic granulomatous inflammatory disorder that can affect any part of the 
gastrointestinal tract from the mouth to the anus with the most common localization in the 
ileocecal region. The etiopathogenesis of CD is unclear, and includes genetic, immunological and 
environmental factors with impaired intestinal microbiota [1]. The incidence of CD has been 
increasing on a global scale, and it appears that is related to a “Western” lifestyle and diet, which 
shows the strong impact of the environment on the CD occurrence [1,2]. The course of CD is 
chronic with periodic exacerbations and remissions of symptoms. Activ CD can be easy assessed 
by clinical and laboratory tests and the CD activity index (CDAI). Patients suffer from abdominal 
pain, often diarrhea, fever, weight loss with subsequent impaired water and electrolyte balance, iron 
deficiency anemia, and nutrient deficiencies [1]. There are several CD complications like fistulas, 
narrowing o f the intestine or intraabdominal abscesses. In about 25% to 80% of patients they are 
localized in perianal region [3]. All CD consequences affect the quality of life and the general state 
of the patient.
CD can manifest with extraintestinal symptoms in many organs including liver, skin, joints, and 
oral cavity. The prevalence o f oral lesions in CD patients vary over a wide range from 5% to 20% due 
to contradictory data [4-6].
Oral CD may precede the intestinal manifestations or may be present at the same time after 
the occurrence of the gastrointestinal symptoms [5,7,8]. Oral CD is important in the diagnosis 
of CD due to its easy access during physical examination, characteristic clinical features, and can 
commonly harbor diagnostically useful material for histopathological examination [6, 9-13].
The CD manifestations in the oral cavity were first described by Dudeney et al.and confirmed by 
other authors [6-9,14-15]. Oral lesions secondary to infection, nutritional deficiency or adverse effect 
of medications have been described more often than a variety of CD-specific lesions characterized 
by noncaseating granulomas of the oral mucosa [6,10-13]. Therefore oral CD is divided into specific 
caused by granulomatous inflammation, and non-specific, caused by various factors [3,4,11,14].
The specific manifestations of CD have been identified and described by Mallins et al., Scheper 
and Brand, Laurenco et al., Harty et al., and others [3,4,9,11,14]. The CD-specific lesions have 
different clinical picture, including diffuse swelling of the lips or cheek, inflammation of the 
mucosa and gingiva, cobblestoning, angular cheilitis, deep linear ulcerations and the mucosal tags 
[3,4,6,9]. Cobblestone appearance o f the mucosa in the posterior buccal region is characteristic oral 
manifestation that can be found in 10% to 12% of patients [4,7,6,11]. Angular cheilitis represents 
the most common oral lesion in CD and may be caused by dietary restrictions during exacerbation 
of symptoms, malabsorption, drug reactions, iron deficiency anemia, deficiency o f vitamin B12, 
folic acid or fat-soluble vitamins [3,6,11]. Aphthous ulcers and oral candidiasis are more frequently 
seen than in healthy subjects [6,9,11,13]. Various factors are involved in the etiopathogenesis of 
oral CD which are still waiting for the elucidation. There are widely discussed the deficiency of 
vitamins, trace elements and other nutritional components, and the underlying CD granulomatous 
inflammation for a proportion of CD-specific lesions.
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